SCHEMBL4480090

SCHEMBL4480090

CC1(C)OC(=O)N(Cl)C1(Cl)c1ccc(-c2ccccc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 5/20 0.36
LPL P06858 1/20 0.36
LIPG Q9Y5X9 1/20 0.36
MMP2 P08253 2/20 0.35
MMP9 P14780 2/20 0.35
MMP3 P08254 1/20 0.35
ELANE P08246 1/20 0.35
CTSG P08311 1/20 0.35
PRTN3 P24158 1/20 0.35
ALDH1A1 P00352 1/20 0.35
KMT2A Q03164 1/20 0.34
GRM2 Q14416 1/20 0.34
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
MMP1 P03956 1/20 0.32
ADAM17 P78536 1/20 0.32
CYP1A2 P05177 1/20 0.32
POLB P06746 1/20 0.32
FAAH O00519 1/20 0.32
MGLL Q99685 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4480093 0.76 ELANE (0.38) HSD11B1LPLLIPGMMP2MMP9
SCHEMBL4450100 0.70 HSD11B1 (0.37) HSD11B1LPLLIPGMMP2MMP9
SCHEMBL4454484 0.67 HSD11B1 (0.34) HSD11B1LPLLIPGMMP2MMP9
SCHEMBL4450103 0.64 GAA (0.40) HSD11B1LPLLIPGMMP2MMP9
SCHEMBL4458256 0.61 IDH1 (0.39) HSD11B1MMP2MMP9MMP3ALDH1A1
SCHEMBL6932927 0.60 CHRNA1 (0.42) LPLLIPGMMP2MMP9MMP3
SCHEMBL7983353 0.60 CHRNA1 (0.42) LPLLIPGMMP2MMP9MMP3
SCHEMBL28376028 0.58 ALDH1A1 (0.45) LPLLIPGMMP2MMP9MMP3
Tannin Pyrogallol SCHEMBL28146848 0.58 ALDH1A1 (0.69) MMP3ALDH1A1CYP1A2MGLLCTRC
SCHEMBL763669 0.57 PKM (0.38) MMP2MMP9ELANECTSGALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090137577-A1 HETEROCYCLIC COMPOUNDS PFIZER INC. 2009-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137577-A1 HETEROCYCLIC COMPOUNDS CYP2D6, ABCG2, CYP2B6 HSD11B1 945/4885LPL 966/4885LIPG 2239/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.